Drawing for IGGY

USPTO serial 87516298

IGGY

Reviewed by CopyMark Law Group

Reg. 5547156Status 702Registered
Filing date
Status date
Registration date
Aug 21, 2018
Examiner
KELLY, JOHN M
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with IGGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark A. Wright

Mark A. Wright MCLANE MIDDLETON PROFESSIONAL ASSOCIATIONP.O. BOX 326MANCHESTER, NH 03105United States

Goods and services

ClassDescriptionStatusFirst use
001Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemical reagents used for non-medical purposes; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polypeptides for in vitro research use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Chemicals for use in the purification of proteins for in vitro use; Diagnostic preparations for scientific or research use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Fluorescent dye for scientific or research use; Immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry; Kit containing pre-packed columns, chemicals, pre-made buffer concentrates, syringes and instructional manual for the purification of proteins for in vitro use; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Protein arrays and nucleotide arrays for scientific and medical research; Protein in raw material form for scientific and medical research; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Reagents and substrates, namely, chemical compounds for use in patterning at nano scale or near nano scale; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research useACTIVESep 30, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 10, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jan 10, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 10, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 14, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Aug 21, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 21, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 14, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 14, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 13, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 13, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 13, 2018EX1GSOU EXTENSION 1 GRANTED—
Jul 13, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 5, 2018EXT1SOU EXTENSION 1 FILED—
Jul 5, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 3, 2018IUAFUSE AMENDMENT FILED—
Jul 3, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 9, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 14, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 14, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 25, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 29, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 29, 2017DOCKASSIGNED TO EXAMINER—
Jul 12, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 8, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance